دورية أكاديمية
Menopausal stages and overactive bladder symptoms in middle-aged women: A cross-sectional study.
| العنوان: | Menopausal stages and overactive bladder symptoms in middle-aged women: A cross-sectional study. |
|---|---|
| المؤلفون: | Park J; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Institute of Medical Research, Sungkyunkwan University School of Medicine, Suwon, Korea., Chang Y; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea., Kim JH; Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea., Choi HR; Institute of Medical Research, Sungkyunkwan University School of Medicine, Suwon, Korea.; Healthcare Data Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Kwon R; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Institute of Medical Research, Sungkyunkwan University School of Medicine, Suwon, Korea., Lim GY; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Institute of Medical Research, Sungkyunkwan University School of Medicine, Suwon, Korea., Ahn J; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim KH; Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim H; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea., Hong YS; Department of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Zhao D; Department of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA., Cho J; Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Korea., Guallar E; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA., Park HY; National Institute of Health, Cheongju, Korea., Ryu S; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea. |
| المصدر: | BJOG : an international journal of obstetrics and gynaecology [BJOG] 2024 Jul 11. Date of Electronic Publication: 2024 Jul 11. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100935741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0528 (Electronic) Linking ISSN: 14700328 NLM ISO Abbreviation: BJOG Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Original Publication: Oxford [England] : Blackwell Science, [2000]- |
| مستخلص: | Objective: To examine the prevalence of overactive bladder (OAB) according to menopausal stages in middle-aged women. Design: Cross-sectional study. Setting: Total Healthcare Center in South Korea. Population: Middle-aged Korean women (n=3469, mean age, 49.5 ± 2.9 years). Methods: Menopausal stages were defined according to the Stages of Reproductive Aging Workshop +10 criteria, and menopausal symptoms were assessed using the Korean version of Menopause-Specific Quality of Life (MENQOL). Logistic regression models were used to estimate prevalence ratios with 95% confidence intervals for OAB according to menopausal stage and to assess the associations with menopausal symptoms. Main Outcome Measures: OAB symptoms were evaluated using the Overactive Bladder Symptom Score (OABSS). Results: The prevalence of OAB increased with menopausal stage; however, the multivariable-adjusted prevalence ratios for women in menopausal transition and postmenopausal stage were insignificant (p Conclusions: The prevalence of OAB, particularly nocturia, increased with menopausal stage, and the association was obvious in women with other menopausal symptoms. This finding underscores the importance of addressing nocturia as a potential menopausal symptom in middle-aged women. Further studies are required to understand the mechanisms linking OAB with menopausal symptoms in middle-aged women. (© 2024 John Wiley & Sons Ltd.) |
| References: | El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, et al. The menopause transition and women's health at midlife: a progress report from the study of Women's health across the nation (SWAN). Menopause. 2019;26(10):1213–1227. Woods NF, Mitchell ES, Coslov N, Richardson MK. Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging. Menopause. 2021;28(4):447–466. Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference P. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's sexual health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub‐committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–178. Cagnacci A, Sclauzero M, Meriggiola C, Xholli A, ANGEL study. Lower urinary tract symptoms and their relation to vaginal atrophy in women across the menopausal age span. Results from the ANGEL multicentre observational study. Maturitas. 2020;140:8–13. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB‐POLL. NeurourolUrodyn. 2013;32(3):230–237. Nagai K, Homma Y, Ideno Y, Hayashi K. Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses' health study. Menopause. 2021;29(2):129–136. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–336. Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. NeurourolUrodyn. 2011;30(8):1448–1455. Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71–76. Muller CJ, MacLehose RF. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. Int J Epidemiol. 2014;43(3):962–970. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000. Chen YC, Chen GD, Hu SW, Lin TL, Lin LY. Is the occurrence of storage and voiding dysfunction affected by menopausal transition or associated with the normal aging process? Menopause. 2003;10(3):203–208. Jones HJ, Huang AJ, Subak LL, Brown JS, Lee KA. Bladder symptoms in the early menopausal transition. J Womens Health (Larchmt). 2016;25(5):457–463. Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM 2nd, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: a population‐based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1–153.12. Lu Z, Zhang J, Lin S, Fan Z, He Z, Tang F. Associations between overactive bladder and sleep patterns: a cross‐sectional study based on 2007‐2014 NHANES. BMC Urol. 2023;23(1):184. Oge T, Hassa H, Aydin Y, Yalcin OT, Colak E. The relationship between urogenital symptoms and climacteric complaints. Climacteric. 2013;16(6):646–652. Terauchi M, Hirose A, Akiyoshi M, Owa Y, Kato K, Kubota T. Prevalence and predictors of storage lower urinary tract symptoms in perimenopausal and postmenopausal women attending a menopause clinic. Menopause. 2015;22(10):1084–1090. Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder ‐ a systematic review. J Psychosom Res. 2015;78(2):95–108. Choi HR, Chang Y, Kim Y, Cho Y, Kwon MJ, Kang J, et al. Vasomotor and other menopause symptoms and the prevalence of ideal cardiovascular health metrics among premenopausal stage women. Menopause. 2023;30(7):750–757. Jeong SJ, Homma Y, Oh SJ. Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J. 2011;15(3):135–142. Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, et al. Clinical guidelines for overactive bladder. Int J Urol. 2009;16(2):126–142. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–395. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the menopause‐specific quality of life questionnaire and development of a modified version, MENQOL‐intervention questionnaire. Maturitas. 2005;50(3):209–221. Weiss JP. Nocturia: focus on etiology and consequences. Rev Urol. 2012;14(3–4):48–55. Gopal M, Sammel MD, Pien G, Gracia C, Freeman EW, Lin H, et al. Investigating the associations between nocturia and sleep disorders in perimenopausal women. J Urol. 2008;180(5):2063–2067. Waetjen LE, Ye J, Feng WY, Johnson WO, Greendale GA, Sampselle CM, et al. Association between menopausal transition stages and developing urinary incontinence. Obstet Gynecol. 2009;114(5):989–998. Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health. 2006;96(7):1226–1235. Pauwaert K, Goessaert AS, Ghijselings L, Monaghan TF, Depypere H, Everaert K. Nocturia through the menopausal transition and beyond: a narrative review. Int Urogynecol J. 2021;32(5):1097–1106. Hu TW, Wagner TH. Health‐related consequences of overactive bladder: an economic perspective. BJU Int. 2005;96(Suppl 1):43–45. Tikkinen KA, Johnson TM 2nd, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population‐based study in Finland. Eur Urol. 2010;57(3):488–496. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–711. Pauwaert K, Goessaert AS, Robinson D, Cardozo L, Bower W, Calders P, et al. Nocturia in menopausal women: the link between two common problems of the middle age. Int Urogynecol J. 2024;35(5):935–946. Cheng CL, Li JR, Lin CH, de Groat WC. Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population‐based cohort study in Taiwan. Medicine (Baltimore). 2016;95(28):e4107. Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand. 2004;83(10):892–897. Pauwaert K, Goessaert AS, Ghijselings L, Bower W, Mariman A, Vogelaers D, et al. Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial. Menopause. 2021;28(5):502–510. Breyer BN, Shindel AW, Erickson BA, Blaschko SD, Steers WD, Rosen RC. The association of depression, anxiety and nocturia: a systematic review. J Urol. 2013;190(3):953–957. Kim MJ, Yim G, Park HY. Vasomotor and physical menopausal symptoms are associated with sleep quality. PLoS One. 2018;13(2):e0192934. Araujo AB, Yaggi HK, Yang M, McVary KT, Fang SC, Bliwise DL. Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J Urol. 2014;191(1):100–106. Aoki Y, Yokoyama O. Metabolic syndrome and nocturia. Low Urin Tract Symptoms. 2012;4(Suppl 1):11–15. |
| معلومات مُعتمدة: | 2020ER710200 Republic of Korea Korea Centers for Disease Control and Prevention; 2020ER710201 Republic of Korea Korea Centers for Disease Control and Prevention; 2020ER710202 Republic of Korea Korea Centers for Disease Control and Prevention; 2023ER060500 Republic of Korea Korea Centers for Disease Control and Prevention; 2023ER060501 Republic of Korea Korea Centers for Disease Control and Prevention |
| فهرسة مساهمة: | Keywords: menopause; middle‐aged women; nocturia; overactive bladder |
| تواريخ الأحداث: | Date Created: 20240712 Latest Revision: 20240712 |
| رمز التحديث: | 20240712 |
| DOI: | 10.1111/1471-0528.17912 |
| PMID: | 38992913 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1471-0528 |
|---|---|
| DOI: | 10.1111/1471-0528.17912 |